GUTS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

GU

Mkt Cap

$20.6M

Volume

14.71M

Next Earnings

November 11th

Loading chart

GU

GUTSFractyl Health, Inc. Common Stock

GUTS

Pay with—

Available Balance0.00

GU

Mkt Cap

$55.2M

Volume

14.71M

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements regarding the effectiveness of its Revita product and the integrity of clinical trial results. The lawsuit covers investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026. The lead plaintiff deadline is October 20, 2026.GlobeNewswire Inc. · Oct 15, 2026

Bragar Eagel & Squire, P.C. Urges Fractyl Health, Inc. Stockholders with Large Losses to Contact the Firm Before October 20thA class action lawsuit has been filed against Fractyl Health, Inc. for allegedly making materially false and misleading statements regarding its Revita product's effectiveness and clinical trial integrity during the period between January 13, 2025 and January 29, 2026. Investors who suffered losses are urged to contact the law firm by October 20, 2026 to participate in the action.GlobeNewswire Inc. · Oct 1, 2026

DEADLINE ALERT for FTK, AVEX, GUTS, GDDY: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class ActionsLaw Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Flotek Industries, Aevex Corp, Fractyl Health, and GoDaddy Inc. The lawsuits allege materially false and misleading statements regarding business operations and prospects. Investors have until October 2026 to file lead plaintiff motions.GlobeNewswire Inc. · Sep 24, 2026

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements about the effectiveness of its Revita product and the integrity of REMAIN-1 clinical trial results. Investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026 may be eligible to join the lawsuit, with a lead plaintiff deadline of October 20, 2026.GlobeNewswire Inc. · Sep 24, 2026

Robbins LLP Urges GUTS Stockholders to Contact the Firm for Information About the Class Action Against Fractyl Health, Inc.Robbins LLP announced a class action lawsuit against Fractyl Health, Inc. (NASDAQ: GUTS) for allegedly misleading investors about the efficacy of its Revita DMR System. The company's stock plummeted 68% on January 29, 2026, after disclosing disappointing six-month clinical trial data that fell short of investor expectations. The lawsuit covers investors who purchased securities between January 13, 2025 and January 29, 2026.GlobeNewswire Inc. · Sep 23, 2026

Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers – GUTSPomerantz LLP filed a class action lawsuit against Fractyl Health, Inc. (NASDAQ: GUTS) for alleged securities fraud. The lawsuit claims defendants made materially false statements about the efficacy of Revita, their diabetes and obesity treatment device. On January 29, 2026, Fractyl disclosed disappointing six-month data from the REMAIN-1 Midpoint Cohort showing only 4.5% weight regain versus 7.5% in the sham arm, and revealed operational issues at one clinical site. The stock price fell 68.03% following the disclosure. The class period covers purchases between January 13, 2025 and January 29, 2026.GlobeNewswire Inc. · Sep 22, 2026

Deadline Alert: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitFractyl Health (GUTS) faces a class action securities fraud lawsuit after disclosing disappointing six-month efficacy data for its Revita treatment on January 29, 2026. The company's weight loss results (4.5% regain vs. 7.5% in control) fell significantly short of investor expectations, causing the stock to plummet 68% to $0.58 per share. Shareholders are urged to file lead plaintiff motions by October 20, 2026, with allegations that defendants made materially false statements about Revita's effectiveness and clinical prospects.GlobeNewswire Inc. · Sep 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements regarding the effectiveness of its Revita product and the integrity of clinical trial results. The lawsuit covers investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026. The lead plaintiff deadline is October 20, 2026.GlobeNewswire Inc. · Sep 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements regarding the effectiveness of its Revita product and the integrity of clinical trial results. The lawsuit covers investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026. The lead plaintiff deadline is October 20, 2026.GlobeNewswire Inc. · Sep 15, 2026

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements regarding the effectiveness of its Revita product and the integrity of clinical trial results. The lawsuit covers investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026. The lead plaintiff deadline is October 20, 2026.GlobeNewswire Inc. · Sep 10, 2026

to start trading

GU

GUTSFractyl Health, Inc. Common Stock

GUTS

Pay with—

Available Balance0.00

Your PositionYou don't own any GUTS yet.

Related Tickers

Earnings